Cargando…

Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection Fraction

BACKGROUND: The CASTLE‐AF (Catheter Ablation versus Standard Conventional Therapy in Patients With Left Ventricular Dysfunction and Atrial Fibrillation) trial recently reported that catheter ablation of atrial fibrillation (AF) improves survival in heart failure (HF) with reduced ejection fraction (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mercer, Ben N., Koshy, Aaron, Drozd, Michael, Walker, Andrew M. N., Patel, Peysh A., Kearney, Lorraine, Gierula, John, Paton, Maria F., Lowry, Judith E., Kearney, Mark T., Cubbon, Richard M., Witte, Klaus K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474978/ https://www.ncbi.nlm.nih.gov/pubmed/30371286 http://dx.doi.org/10.1161/JAHA.118.009770

Ejemplares similares

Prevalence and Predictors of Sepsis Death in Patients With Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction
por: Walker, Andrew M. N., et al.
Publicado: (2018)

Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure
por: Gierula, John, et al.
Publicado: (2022)

Effect of disease‐modifying agents and their association with mortality in multi‐morbid patients with heart failure with reduced ejection fraction
por: Straw, Sam, et al.
Publicado: (2020)

Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
por: Straw, Sam, et al.
Publicado: (2022)

Vitamin D deficiency is an independent predictor of mortality in patients with chronic heart failure
por: Cubbon, Richard M., et al.
Publicado: (2018)

Diabetes, gender and deterioration in estimated glomerular filtration rate in patients with chronic heart failure: Ten-year prospective cohort study
por: Kearney, Jessica, et al.
Publicado: (2021)

Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification
por: Cubbon, Richard M, et al.
Publicado: (2016)

Socioeconomic deprivation and mode-specific outcomes in patients with chronic heart failure
por: Witte, Klaus K, et al.
Publicado: (2018)

Association of heart failure and its comorbidities with loss of life expectancy
por: Drozd, Michael, et al.
Publicado: (2021)

Prioritizing symptom management in the treatment of chronic heart failure
por: Koshy, Aaron O., et al.
Publicado: (2020)

Diabetes mellitus and the causes of hospitalisation in people with heart failure
por: Malik, Anam, et al.
Publicado: (2022)

Can the development of atrial fibrillation in patients with ischemic heart failure with low ejection fraction be predicted?
por: Alpsoy, Seref, et al.
Publicado: (2019)

Chronic heart failure with diabetes mellitus is characterized by a severe skeletal muscle pathology
por: Garnham, Jack O., et al.
Publicado: (2019)

Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2021)

Optimising pacemaker therapy and medical therapy in pacemaker patients for heart failure: protocol for the OPT-PACE randomised controlled trial
por: Paton, Maria F, et al.
Publicado: (2019)

Breaking the Cycle of Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation
por: Ţica, Otilia, et al.
Publicado: (2022)

Divergent skeletal muscle mitochondrial phenotype between male and female patients with chronic heart failure
por: Garnham, Jack O., et al.
Publicado: (2019)

Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure
por: Cubbon, Richard M, et al.
Publicado: (2016)

Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation( )
por: Kondo, Toru, et al.
Publicado: (2022)

Suboptimal Dosing of β-Blockers in Chronic Heart Failure: A Missed Opportunity?
por: McGinlay, Melanie, et al.
Publicado: (2022)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis
por: van den Berg, Maarten P, et al.
Publicado: (2019)

The prognostic impact of mechanical atrial dysfunction and atrial fibrillation in heart failure with preserved ejection fraction
por: Weerts, Jerremy, et al.
Publicado: (2021)

Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction
por: Yang, Eunice, et al.
Publicado: (2022)

Ivabradine in heart failure patients with reduced ejection fraction and history of paroxysmal atrial fibrillation
por: Lin, Yu‐Sheng, et al.
Publicado: (2022)

Liver fibrosis scores and atrial fibrillation incidence in heart failure with preserved ejection fraction
por: Liu, Xiao, et al.
Publicado: (2022)

Rhythm versus rate control for atrial fibrillation in heart failure with preserved ejection fraction
por: Al-Sadawi, Mohammed, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction and atrial fibrillation: recent advances and open questions
por: Fauchier, Laurent, et al.
Publicado: (2023)

Insights on Distinct Left Atrial Remodeling Between Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction
por: Kuo, Jen-Yuan, et al.
Publicado: (2022)

Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA‐HF
por: Butt, Jawad H., et al.
Publicado: (2021)

Advanced care planning during the COVID-19 pandemic: ceiling of care decisions and their implications for observational data
por: Straw, Sam, et al.
Publicado: (2021)

Correction: Advanced care planning during the COVID-19 pandemic: ceiling of care decisions and their implications for observational data
por: Straw, Sam, et al.
Publicado: (2022)

Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction
por: McDiarmid, Adam K., et al.
Publicado: (2019)

Atrial Fibrillation and Outcomes in Heart Failure With Preserved Versus Reduced Left Ventricular Ejection Fraction
por: McManus, David D., et al.
Publicado: (2013)

Atrial fibrillation in heart failure with reduced ejection fraction: a case report of exercise training
por: Guimarães, Guilherme Veiga, et al.
Publicado: (2020)

Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction
por: Son, Mi Kyoung, et al.
Publicado: (2020)

Heart Failure and Atrial Fibrillation: Diastolic Function Differences Depending on Left Ventricle Ejection Fraction
por: Horodinschi, Ruxandra-Nicoleta, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation
por: Ariyaratnam, Jonathan P., et al.
Publicado: (2021)

Atrial fibrillation ablation in patients with heart failure with preserved ejection fraction: Complexities in diagnosis and treatment
por: Ariyaratnam, Jonathan P., et al.
Publicado: (2022)

Outcomes of patients with heart failure with preserved ejection fraction undergoing catheter ablation of atrial fibrillation
por: Krishnamurthy, Amrita, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r0mef24qrfa79lenvv202opb5n